Impax Laboratories Inc. (IPXL) Tops Q3 EPS by 7c; Revs Light
Tweet
Share
E-mailGet Alerts IPXL Hot Sheet
Join SI Premium – FREE
Impax Laboratories Inc. (NASDAQ: IPXL) reported Q3 EPS of $0.30, $0.07 better than the analyst estimate of $0.23. Revenue for the quarter came in at $119.8 million versus the consensus estimate of $128.17 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Beyond Air, Inc. (XAIR) Tops Q1 reported Q1 Revenue ; Offers Guidance
- Stratasys (SSYS) Tops Q2 EPS by 2c ;; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
